Literature DB >> 23557893

Myeloid sarcoma of the cheek and the maxillary sinus regions.

Kai-Di Mei1, Yung-Song Lin, Shih-Lun Chang.   

Abstract

Myeloid sarcoma (MS) is a rare, extramedullary malignant tumor composed of immature myeloid precursor cells and myeloblast. Most MSs occur in the subperiosteal region of the bone, with the skull, sternum, ribs, and proximal portions of the long bones being the common sites of involvement. It is thought that the MS tumor originates in the bone marrow, and traverses the Haversian canals to reach the subperiosteum. Various reports have also described the involvement of the liver, spleen, brain, heart, pharynx, uterus, vagina, skin, kidney, and other soft tissues in the formation of the tumor.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2013        PMID: 23557893     DOI: 10.1016/j.jcma.2012.12.005

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  4 in total

1.  Immunohistochemical patterns in the differential diagnosis of rhinopharyngeal granulocytic sarcoma.

Authors:  Elena Cantone; Michele Cavaliere; Antonella Miriam Di Lullo; Elia Guadagno; Maurizio Iengo
Journal:  Oncol Lett       Date:  2016-08-16       Impact factor: 2.967

Review 2.  A case of myeloid sarcoma of the mandibular gingiva as extramedullary relapse of acute myeloid leukemia.

Authors:  Shigeo Ishikawa; Yuichi Kato; Takanobu Kabasawa; Chiho Yoshioka; Kenichiro Kitabatake; Mitsunori Yamakawa; Kenichi Ishizawa; Mitsuyoshi Iino
Journal:  Oral Maxillofac Surg       Date:  2019-12-01

3.  Isolated granulocytic sarcoma of the nasopharynx: a case report and review of the literature.

Authors:  Prakash Vishnu; Ravindra Reddy Chuda; Dick G Hwang; David M Aboulafia
Journal:  Int Med Case Rep J       Date:  2013-12-17

Review 4.  Clinical characteristics and management of primary granulocytic sarcoma of the oral cavity: A case report and literature review.

Authors:  Yun-Gang Hu; Xiao-Hua Deng; Wei Lei; Xiao-Lin Li
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.